Correlation of pre-operative CT findings with surgical & histological tumor dissemination patterns at cytoreduction for primary advanced and relapsed epithelial ovarian cancer: A retrospective evaluation

被引:30
作者
Nasser, S. [1 ]
Lazaridis, A. [1 ]
Evangelou, M. [2 ]
Jones, B. [1 ]
Nixon, K. [1 ,3 ]
Kyrgiou, M. [1 ,3 ]
Gabra, H. [1 ,3 ]
Rockall, A. [4 ]
Fotopoulou, C. [1 ,3 ]
机构
[1] Imperial Coll London, West London Gynecol Canc Ctr, Du Cane Rd, London W12 0HS, England
[2] Imperial Coll, Dept Math & Stat, Huxley Bldg,Queens Gate South Kensington Campus, London SW7 2AZ, England
[3] Imperial Coll London, Dept Surg & Canc, Ovarian Canc Act Res Ctr, Du Cane Rd, London W12 0HS, England
[4] Imperial Coll, Dept Radiol, Canc Imaging Ctr, Du Cane Rd, London W12 0HS, England
基金
美国国家卫生研究院;
关键词
Pre-operative imaging; Cr; Ovarian cancer; COMPUTED-TOMOGRAPHY; DEBULKING SURGERY; CONSECUTIVE PATIENTS; STAGE-III; CARCINOMA; MRI; PREDICTORS; RESECTION; BENEFIT; PET/CT;
D O I
10.1016/j.ygyno.2016.08.322
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. Computed tomography (CT) is an essential part of preoperative planning prior to cytoreductive surgery for primary and relapsed epithelial ovarian cancer (EOC). Our aim is to correlate pre-operative CT results with intraoperative surgical and histopathological findings at debulking surgery. Methods. We performed a systematic comparison of intraoperative tumor dissemination patterns and surgical resections with preoperative CT assessments of infiltrative disease at key resection sites, in women who underwent multivisceral debulking surgery due to EOC between January 2013 and December 2014 at a tertiary referral center. The key sites were defined as follows: diaphragmatic involvement(DI), splenic disease (SI), large (LBI) and small (SBI) bowel involvement, rectal involvement (RI), porta hepatis involvement (PHI), mesenteric disease (MI) and lymph node involvement (LNI). Results. A total of 155 patients, mostly with FIGO stage IIIC disease (65%) were evaluated (primary = 105, relapsed = 50). Total macroscopic cytoreduction rates were: 89%. Pre-operative CT findings displayed high specificity across all tumor sites apart from the retroperitoneal lymph node status, with a specificity of 65%. The ability however of the CT to accurately identify sites affected by invasive disease was relatively low with the following sensitivities as relating to final histology: 32% (DI), 26% (SI), 46% (LBI), 44% (SBI), 39% (RI), 57% (PHI), 31% (MI), 63% (LNI). Conclusion. Pre-operative CT imaging shows high specificity but low sensitivity in detecting tumor involvement at key sites in ovarian cancer surgery. CT findings alone should not be used for surgical decision making. Crown Copyright (C) 2016 Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:264 / 269
页数:6
相关论文
共 33 条
  • [1] Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer
    Axtell, Allison E.
    Lee, Margaret H.
    Bristow, Robert E.
    Dowdy, Sean C.
    Cliby, William A.
    Raman, Steven
    Weaver, John P.
    Gabbay, Mojan
    Ngo, Michael
    Lentz, Scott
    Cass, Ilana
    Li, Andrew J.
    Karlan, Beth Y.
    Holschneider, Christine H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (04) : 384 - 389
  • [2] Balestreri Luca, 2002, Radiol Med, V104, P426
  • [3] Radiological predictors of cytoreductive outcomes in patients with advanced ovarian cancer
    Borley, J.
    Wilhelm-Benartzi, C.
    Yazbek, J.
    Williamson, R.
    Bharwani, N.
    Stewart, V.
    Carson, I.
    Hird, E.
    McIndoe, A.
    Farthing, A.
    Blagden, S.
    Ghaem-Maghami, S.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 122 (06) : 843 - 849
  • [4] Bristow RE, 2000, CANCER, V89, P1532, DOI 10.1002/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO
  • [5] 2-A
  • [6] COMPARATIVE-EVALUATION OF DIAGNOSTIC METHODS IN OVARIAN-CARCINOMA WITH EMPHASIS ON CT AND MRI
    BUIST, MR
    GOLDING, RP
    BURGER, CW
    VERMORKEN, JB
    KENEMANS, P
    SCHUTTER, EMJ
    BAAK, JPA
    HEITBRINK, MA
    FALKE, THM
    [J]. GYNECOLOGIC ONCOLOGY, 1994, 52 (02) : 191 - 198
  • [7] Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 Trial
    Crawford, SC
    Vasey, PA
    Paul, J
    Hay, A
    Davis, JA
    Kaye, SB
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) : 8802 - 8811
  • [8] Dowdy S.C., 2004, CANCER, V101, P2
  • [9] OVARIAN-CANCER - STAGING WITH CT AND MR-IMAGING
    FORSTNER, R
    HRICAK, H
    OCCHIPINTI, KA
    POWELL, CB
    FRANKEL, SD
    STERN, JL
    [J]. RADIOLOGY, 1995, 197 (03) : 619 - 626
  • [10] Can complete tumor resection be predicted in advanced primary epithelial ovarian cancer? A systematic evaluation of 360 consecutive patients
    Fotopoulou, C.
    Richter, R.
    Braicu, E. I.
    Schmidt, S. -C.
    Lichtenegger, W.
    Sehouli, J.
    [J]. EJSO, 2010, 36 (12): : 1202 - 1210